Physician profile
Ben Larson
NPI 1316047079
$1,156.60
in general payments reported to CMS, 2019-2025
16 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $17.21 · 2021: $70.08 · 2022: $238 · 2023: $51.00 · 2024: $138 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393 · Gift: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.42 |
| Gift | $251.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Walman Optical Company | $251.50 | 2025 | Optimum Extra |
| Carl Zeiss Meditec, INC. | $150.00 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $117.52 | 2019 | |
| Rxsight INC | $110.13 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Johnson & Johnson Vision Care, INC. | $82.63 | 2022-2025 | |
| Biotissue Holdings INC. | $70.87 | 2024 | |
| Alcon Vision LLC | $61.54 | 2019-2025 | Precision7 |
| Novartis Pharmaceuticals Corporation | $55.32 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $53.64 | 2021 | |
| Genzyme Corporation | $50.00 | 2025 | |
| Harrow Eye, LLC | $39.39 | 2024 | Vevye |
| Horizon Therapeutics Plc | $30.03 | 2023 | Tepezza |
| Dompe US, INC. | $27.88 | 2024 | Oxervate |
| Coopervision INC. | $20.97 | 2023 | Myday Contact Lens |
| Shire North American Group INC | $17.97 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $17.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.